Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

SANN

Hisse Senetlerindeki Sıralama #16270
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Hisse Fiyatı
$18.73
Piyasa Değeri
$286.57M
Değişim (1 gün)
-0.14%
Değişim (1 yıl)
42.91%
Ülke
CH
Ticaret Santhera Pharmaceuticals Holding AG (SANN)

Kategori

Healthcare
B piyasa değeri ile SANN fiyatı
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG
SANN
$18.73
Piyasa Değeri Santhera Pharmaceuticals Holding AG(SANN)
Piyasa Değeri: $286.57M
October 2026 itibarıyla Santhera Pharmaceuticals Holding AG şirketinin piyasa değeri $286.57M. Bu, verilerimize göre Santhera Pharmaceuticals Holding AG şirketini dünyanın en değerli 16270th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Santhera Pharmaceuticals Holding AG piyasa değeri geçmişi (2014 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında SANN
SANN’in Fiyatı B Varlığı B’nin Piyasa Değeri Sonuçlar
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG
$345,269 $282.17M
$5.235T +1,855,086.66%
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG
$330,453 $282.17M
$5.010T +1,775,480.05%
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG
$274,387 $282.17M
$4.160T +1,474,228.15%
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG
$261,793 $282.17M
$3.969T +1,406,554.66%
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG
$186,660 $282.17M
$2.830T +1,002,855.59%